Jason Wittes
Stock Analyst at Roth MKM
(3.13)
# 1,151
Out of 4,876 analysts
62
Total ratings
50%
Success rate
0.65%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Buy | $405 → $456 | $393.55 | +15.87% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $2.43 | +558.44% | 2 | Mar 21, 2025 | |
| MGRM Monogram Technologies | Maintains: Buy | $4 → $5.4 | $2.87 | +88.15% | 2 | Mar 18, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $1.82 | +779.12% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $11.09 | +98.38% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $60.84 | +18.34% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $5.32 | +106.77% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $58.60 | +96.25% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $6.55 | +449.62% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $7.14 | +54.06% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.41 | +609.22% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $82.57 | +21.11% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.29 | +118.34% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.38 | +552.17% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $31.78 | +136.00% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $11.08 | +98.56% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $91.46 | +31.20% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $168.21 | +22.47% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $216.13 | -32.91% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $13.06 | +14.85% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $18.00 | +1,011.11% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $36.72 | -29.19% | 1 | Feb 22, 2017 |
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $393.55
Upside: +15.87%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $2.43
Upside: +558.44%
Monogram Technologies
Mar 18, 2025
Maintains: Buy
Price Target: $4 → $5.4
Current: $2.87
Upside: +88.15%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $1.82
Upside: +779.12%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $11.09
Upside: +98.38%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $60.84
Upside: +18.34%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.32
Upside: +106.77%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $58.60
Upside: +96.25%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $6.55
Upside: +449.62%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $7.14
Upside: +54.06%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.41
Upside: +609.22%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $82.57
Upside: +21.11%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.29
Upside: +118.34%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.38
Upside: +552.17%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $31.78
Upside: +136.00%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $11.08
Upside: +98.56%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $91.46
Upside: +31.20%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $168.21
Upside: +22.47%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $216.13
Upside: -32.91%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $13.06
Upside: +14.85%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $18.00
Upside: +1,011.11%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $36.72
Upside: -29.19%